The company's three-dose regimen Covid-19 vaccine is the second indigenously developed vaccine to apply for such permission after Bharat Biotech's Covaxin.
Cadila Healthcare is the listed entity of the group. ZRC-3308 has been found to be safe and well tolerated in animal toxicology studies.
IMA took strong exception to Ramdev's comments in a viral video where he said allopathy is a "stupid science" and lakhs of people have died after taking allopathic medicines.
At a press conference, NITI Aayog member (health) Dr V K Paul said Drugs Controller General of India (DCGI) has granted permission for emergency use of the drug after looking at the data.
The Drugs Controller General of India (DGCI) has approved the oral drug for emergency use as an adjunct therapy in moderate to severe coronavirus patients, the defence ministry said.
Bharat Biotech will conduct trials in 525 healthy volunteers. the vaccine will be given by intramuscular route in two doses at day 0 and day 28.
Vaccine shortage: Serum Institute to produce 10 crore doses by August, Bharat Biotech promises 7.8 crore jabs
The sources said the Union Health Ministry and the office of Drugs Controller General of India had sought from both the firms their production plan for June, July, August and September.
According to sources, around 10 crore doses of the Sputnik V vaccine is likely to be imported for emergency use in the country in the next six to seven months.
Further, Bharat Biotech was asked to present the details of the primary and secondary objectives and various assessments to be carried out in the subjects.